Fig. 5From: A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patientsa Kaplan–Meier diagram of survival. b Hazard function diagram in metastatic patients who received intervention (BCc1nanomedicine or placebo capsule) and chemotherapy simultaneouslyBack to article page